Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
PHARMASEAL will offer the Engility® CTMS solution at no cost for COVID-19 Coronavirus clinical trials.
read more
PHARMASEAL has announced a second major release of its Engility CTMS platform.
read more
Thursday, January 24, 2019
PHARMASEAL has launched Engility CTMS, the first product to be released from its Engility B2B platform.
read more
Pharmascience Inc. announced a major expansion of its sterile injectable manufacturing facility in Candiac, Québec, supported by partners with Innovation, Science and Economic Development Canada's Strategic Innovation Fund and by the Government of ...
read more
Tuesday, January 11, 2022
Pharmaron acquires commercial API manufacturing facility in the United Kingdom from Recipharm, and continues to strengthen the global chemistry and manufacturing capabilities and capacities.
read more
Monday, September 26, 2016
Pharmaron has entered into a non-binding Heads of Terms (HoTs) with Merck Sharpe & Dohme Limited (MSD) for the sale of the Hoddesdon UK site which includes MSD’s process development and research facility. The parties hope to complete the deal in Q1 ...
read more
Pharmaron, a fully integrated contract research organization offering R&D services for the life science industry, has announced the acquisition of Xceleron Inc. Xceleron is a Maryland, US-based globally leading Accelerator Mass Spectrometry (AMS) ...
read more
Tuesday, February 28, 2017
Pharmaron, a fully integrated contract research organization offering R&D services to the life sciences industry, has signed a definitive agreement under which Pharmaron will acquire a majority stake in Shin Nippon Biomedical Laboratories Clinical ...
read more
Wednesday, March 03, 2021
Pharmaron Beijing has entered into a definitive agreement to acquire Allergan Biologics Limited in Liverpool, UK, for US$118.7 million in cash from AbbVie.
read more
Monday, November 16, 2020
Pharmaron Beijing has acquired 100% of the equity of Absorption Systems for up to US$137.5 million in cash.
read more
Wednesday, August 05, 2020
Sonoco ThermoSafe is building PharmaPortal, a vendor-neutral blockchain platform for use by pharmaceutical manufacturers and carriers.
read more
PharmaMar announced an agreement with Specialised Therapeutics Asia to market the marine-based anti-tumour compound of the company, lurbinectedin.
read more
PharmaMar reported to National Securities Market Commission that Chugai Pharmaceutical had exercised its right to terminate without cause the License, Development and Commercialization Agreement for Zepsyre in Japan entered on December 22nd, 2016.
read more
Tuesday, November 07, 2017
PharmaMar announced a licensing agreement with Boryung Pharm to commercialize the marine-derived anticancer drug Zepsyre, if approved, in South Korea.
read more
Tuesday, January 28, 2020
PharmaMar and Bionical Emas have announced the launch of an EAP for lurbinectedin to treat patients in the United States with relapsed SCLC, who are unable to enter clinical trials and there are no appropriate alternative treatments.
read more